reference/7225705

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7225705

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study
endingPage	170
issn	1557-9190
issueIdentifier	3
pageRange	166-170
publicationName	Clinical Lymphoma and Myeloma
startingPage	166
bibliographicCitation	Hayslip JW, Simpson KN. Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun;8(3):166–70. doi: 10.3816/clm.2008.n.020. PMID: 18650180.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39b770073103fbaf5aac63e9a83e0776 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1aecf41b55a87f8595ec3bf375b81ce
date	200806
identifier	https://pubmed.ncbi.nlm.nih.gov/18650180 https://doi.org/10.3816/clm.2008.n.020
isPartOf	https://portal.issn.org/resource/ISSN/1557-9190 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32602
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cost-Effectiveness of Extended Adjuvant Rituximab for US Patients Aged 65–70 Years with Follicular Lymphoma in Second Remission
discusses	http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0005485
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D000911Q000191 http://id.nlm.nih.gov/mesh/D008224Q000188 http://id.nlm.nih.gov/mesh/D008954 http://id.nlm.nih.gov/mesh/D000970Q000191 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D008224Q000191
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003520Q000191 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D003365Q000379 http://id.nlm.nih.gov/mesh/D008224Q000401 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D000971Q000191 http://id.nlm.nih.gov/mesh/D014750Q000191 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D017024Q000379 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011241Q000191 http://id.nlm.nih.gov/mesh/D004317Q000031 http://id.nlm.nih.gov/mesh/D004317Q000191 http://id.nlm.nih.gov/mesh/D012074Q000379 http://id.nlm.nih.gov/mesh/D017024Q000191 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D004317Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 74.